<div class="container">

<table style="width: 100%;"><tr>
<td>data2</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>RPEXE_fitting</h2>

<h3>Description</h3>

<p>A breast cancer clinical trial dataset in Adelson et al. (2016).
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(data2)
</code></pre>


<h3>Details</h3>


<ul>
<li>
<p> first column - times : time to event
</p>
</li>
<li>
<p> second column - censor : censoring status; 0=censored, 1=event.
</p>
</li>
<li>
<p> third column - group : labels the single agent arm and combination arm
</p>
</li>
</ul>
<h3>References</h3>

<p>[1] Adelson, K. B., Ramaswamy, B., Sparano, J. A., Christos, P. J., Wright, J. J., Raptis, G., Han, G., Villalona-Calero, M., Ma, C., Hershman, D., Baar, J., Klein, P., Cigler, T., Budd, T., Novik, Y., Tan, A.R., Tannenbaum, S., Goel, A., Levine, E., Shapiro, C. L., Andreopoulou, E., Naughton, M., Kalinsky, K., Waxman, S., Germain, D. (2016) â€œRandomized Phase II Trial of Fulvestrant Alone or in Combination with Bortezomib in Hormone Receptor-Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitors: A New York Cancer Consortium Trial," Nature Partner Journals Breast Cancer, Volume 2, Article ID 16037, DOI: 10.1038/npjbcancer.2016.37.
</p>


</div>